Lower Respiratory Tract Samples Are Reliable for Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Diagnosis and Animal Model Study

Ren-Rong Tian,Cui-Xian Yang,Mi Zhang,Xiao-Li Feng,Rong-Hua Luo,Zi-Lei Duan,Jian-Jian Li,Jia-Fa Liu,Dan-Dan Yu,Ling Xu,Hong-Yi Zheng,Ming-Hua Li,Hong-Li Fan,Jia-Li Wang,Xing-Qi Dong,Yong-Tang Zheng

DOI: https://doi.org/10.24272/j.issn.2095-8137.2020.329

2021-01-01

Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) continue to impact countries worldwide. At present, inadequate diagnosis and unreliable evaluation systems hinder the implementation and development of effective prevention and treatment strategies. Here, we conducted a horizontal and longitudinal study comparing the detection rates of SARS-CoV-2 nucleic acid in different types of samples collected from COVID-19 patients and SARS-CoV-2-infected monkeys. We also detected anti-SARS-CoV-2 antibodies in the above clinical and animal model samples to identify a reliable approach for the accurate diagnosis of SARS-CoV-2 infection. Results showed that, regardless of clinical symptoms, the highest detection levels of viral nucleic acid were found in sputum and tracheal brush samples, resulting in a high and stable diagnosis rate. Anti-SARS-CoV-2 immunoglobulin M (IgM) and G (IgG) antibodies were not detected in 6.90% of COVID-19 patients. Furthermore, integration of nucleic acid detection results from the various sample types did not improve the diagnosis rate. Moreover, dynamic changes in SARS-CoV-2 viral load were more obvious in sputum and tracheal brushes than in nasal and throat swabs. Thus, SARS-CoV-2 nucleic acid detection in sputum and tracheal brushes was the least affected by infection route, disease progression, and individual differences. Therefore, SARS-CoV-2 nucleic acid detection using lower respiratory tract samples alone is reliable for COVID-19 diagnosis and study.